Showing results (401-410 of 725) with videos related to
Sort By:
Pageof 73
Journal of Hypertension|December 1, 1988
Renin-angiotensin and vasopressin in the development of salt-induced hypertensionI Gavras, R Mulinari, H GavrasRevue Medicale Suisse|February 9, 2006
[Understanding Raynaud's phenomenon: towards a better treatment]P A Bart, B WaeberClinical Pharmacology and Therapeutics|May 1, 1981
Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin IJ Biollaz, M Burnier, G A Turini, et al.Journal of Cardiovascular Pharmacology|January 1, 1991
Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension SocietyT F Lüscher, B WaeberJournal of Cardiovascular Pharmacology|February 1, 1993
Efficacy and safety of various combination therapies based on a calcium antagonist in essential hypertension: results of a placebo-controlled randomized trialT F Lüscher, B WaeberJournal of Hypertension|November 29, 2001
The alpha2 -adrenergic receptors in hypertension and heart failure: experimental and clinical studiesI Gavras, A J Manolis, H GavrasThe American Journal of Physiology|February 1, 1981
Evidence for bradykinin potentiation by angiotensin congeners in conscious ratsS C Textor, H Brunner, H GavrasJournal of the American Society of Nephrology : JASN|April 14, 1999
Comparative antihypertensive effects of angiotensin II receptor antagonistsM Burnier, H R BrunnerPharmacology & Therapeutics|December 18, 2001
Is nitric oxide overproduction the target of choice for the management of septic shock?F Feihl, B Waeber, L LiaudetJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 14, 2001
Relevance of clinical pharmacological models for the evaluation of therapeutic dose range of an AT1-receptor antagonistH R Brunner, J NussbergerPageof 73